Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124160462 | 12416046 | 2 | F | 20160516 | 20160702 | 20160530 | 20160706 | EXP | US-GILEAD-2016-0212248 | GILEAD | 79.00 | YR | E | F | Y | 108.39000 | KG | 20160706 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124160462 | 12416046 | 1 | PS | AMBRISENTAN | AMBRISENTAN | 1 | Unknown | 5 MG, QD | 1412805A | 22081 | 5 | MG | TABLET | QD | |||||
| 124160462 | 12416046 | 2 | SS | ADCIRCA | TADALAFIL | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124160462 | 12416046 | 1 | Product used for unknown indication |
| 124160462 | 12416046 | 2 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124160462 | 12416046 | OT |
| 124160462 | 12416046 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124160462 | 12416046 | Chills | |
| 124160462 | 12416046 | Coronary artery bypass | |
| 124160462 | 12416046 | Dyspnoea | |
| 124160462 | 12416046 | Malaise | |
| 124160462 | 12416046 | Tremor | |
| 124160462 | 12416046 | Unevaluable event | |
| 124160462 | 12416046 | Vascular graft |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |